Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Dec;10(6):872–877. doi: 10.1128/aac.10.6.872

Comparison of the Epidemiology of Bacterial Resistance to Mecillinam and Ampicillin

J D Anderson *, Monica A Adams †, Jane C Barrington †, W N Spence †, C A Shepherd †
PMCID: PMC429857  PMID: 1051328

Abstract

Mecillinam is a new type of β-lactam antibiotic (an amidinopenicillanic acid) that is particularly active against Enterobacteriaceae and is taken orally as in the form of an ester, pivmecillinam. Assessment of any new antibiotic should include a survey of levels of bacterial resistance and investigation of its capacity to select resistant organisms or harm the commensal flora. Antibiotic resistance patterns of 2,000 Enterobacteriaceae isolated from the urine of patients with significant urinary tract infections were therefore determined. Mecillinam-resistant Enterobacteriaceae were found to be much less common than ampicillin-amoxycillin-resistant organisms both in the community and in hospital patients. Most ampicillin-resistant Enterobacteriaceae from infected urines were susceptible to mecillinam, but the relatively rare mecillinam-resistant organisms were usually resistant to ampicillin and cephaloridine. The fecal flora of 26 healthy volunteers who served as controls or were given repeated courses of therapeutic doses of either ampicillin or pivmecillinam was studied. Pivmecillinam had only a transient effect on the aerobic fecal flora and in contrast to ampicillin did not increase populations of resistant Enterobacteriaceae, which would be a potential hazard to the patient and contaminate the environment.

Full text

PDF
872

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson E. S. The ecology of transferable drug resistance in the enterobacteria. Annu Rev Microbiol. 1968;22:131–180. doi: 10.1146/annurev.mi.22.100168.001023. [DOI] [PubMed] [Google Scholar]
  2. Anderson J. D. Factors that may prevent transfer of anti-biotic resistance between gram-negative bacteria in the gut. J Med Microbiol. 1975 Feb;8(1):83–88. doi: 10.1099/00222615-8-1-83. [DOI] [PubMed] [Google Scholar]
  3. Anderson J. D., Gillespie W. A., Richmond M. H. Chemotherapy and antibiotic-resistance transfer between Enterobacteria in the human gastro-intestinal tract. J Med Microbiol. 1973 Nov;6(4):461–473. doi: 10.1099/00222615-6-4-461. [DOI] [PubMed] [Google Scholar]
  4. Anderson J. D. The effect of R-factor carriage on the survival of Escherichia coli in the human intestine. J Med Microbiol. 1974 Feb;7(1):85–90. doi: 10.1099/00222615-7-1-85. [DOI] [PubMed] [Google Scholar]
  5. Anderson J. D., Warner M., Forshaw H. L. Studies on the effect of amoxycillin and ampicillin on Enterobacteriaceae in an experimental model of urinary infection. J Antimicrob Chemother. 1975 Jun;1(2):197–204. doi: 10.1093/jac/1.2.197. [DOI] [PubMed] [Google Scholar]
  6. Bentzen A. J., Vejlsgaard R., Jacobsen J., Tybring L. Clinical evaluation of a novel beta-lactam antibiotic: pivmecillinam (FL 1039). Infection. 1975;3(3):154–160. doi: 10.1007/BF01641339. [DOI] [PubMed] [Google Scholar]
  7. Christoffersen J. C., Iversen H. G., Jacobsen J., Korner B., Petersen H. K., Rasmussen F., Tybring L. FL 1039 in bacteriuria following prostatectomy. A double-blind comparison with pivampicillin and placebo. Scand J Urol Nephrol. 1974;8(3):185–192. doi: 10.3109/00365597409132127. [DOI] [PubMed] [Google Scholar]
  8. Datta N., Faiers M. C., Reeves D. S., Brumfitt W., Orskov F., Orskov I. R Factors in Escherichia coli in faeces after oral chemotherapy in general practice. Lancet. 1971 Feb 13;1(7694):312–315. doi: 10.1016/s0140-6736(71)91042-7. [DOI] [PubMed] [Google Scholar]
  9. Datta N. Prevalence of extrachromosomal drug resistance. R Factors in Escherichia coli. Ann N Y Acad Sci. 1971 Jun 11;182:59–64. doi: 10.1111/j.1749-6632.1971.tb30643.x. [DOI] [PubMed] [Google Scholar]
  10. Finland M. I. Prevalence of extrachromosomal drug resistance. Changes in asusceptibility of selected pathogenic bacteria to widely used antibiotics. Ann N Y Acad Sci. 1971 Jun 11;182:5–20. doi: 10.1111/j.1749-6632.1971.tb30639.x. [DOI] [PubMed] [Google Scholar]
  11. Greenwood D., Brooks H. L., Gargan R., O'Grady F. Activity of FL 1060, a new beta-lactam antibiotic, against urinary tract pathogens. J Clin Pathol. 1974 Mar;27(3):192–197. doi: 10.1136/jcp.27.3.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jonsson M. Antibiotic resistance and R factors in gram-negative bacteria isolated in a hospital for infectious diseases. 3. The effect of antibacterial treatment on the incidence of R factor-mediated antibiotic resistance. Scand J Infect Dis. 1973;5(1):41–47. doi: 10.3109/inf.1973.5.issue-1.08. [DOI] [PubMed] [Google Scholar]
  13. Lacey R. W. A critical appraisal of the importance of R-factors in the Enterobacteriaceae in vivo. J Antimicrob Chemother. 1975 Mar;1(1):25–37. doi: 10.1093/jac/1.1.25. [DOI] [PubMed] [Google Scholar]
  14. Lowbury E. J., Babb J. R., Roe E. Clearance from a hospital of gram-negative bacilli that transfer carbenicillin-resistance to Pseudomonas aeruginosa. Lancet. 1972 Nov 4;2(7784):941–945. doi: 10.1016/s0140-6736(72)92469-5. [DOI] [PubMed] [Google Scholar]
  15. Lund F., Tybring L. 6 -amidinopenicillanic acids--a new group of antibiotics. Nat New Biol. 1972 Apr 5;236(66):135–137. doi: 10.1038/newbio236135a0. [DOI] [PubMed] [Google Scholar]
  16. Matsuhashi S., Kamiryo T., Blumberg P. M., Linnett P., Willoughby E., Strominger J. L. Mechanism of action and development of resistance to a new amidino penicillin. J Bacteriol. 1974 Feb;117(2):578–587. doi: 10.1128/jb.117.2.578-587.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moorhouse E. C., Farrell W. Effect of co-trimoxazole on faecal enterobacteria: no emergence of resistant strains. J Med Microbiol. 1973 May;6(2):249–252. doi: 10.1099/00222615-6-2-249. [DOI] [PubMed] [Google Scholar]
  18. Neu H. C. Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria. Antimicrob Agents Chemother. 1976 May;9(5):793–799. doi: 10.1128/aac.9.5.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Näff H. Uber die Veränderungen der normalen Darmflora des Menschen durch Bactrim. Pathol Microbiol (Basel) 1971;37(1):1–22. [PubMed] [Google Scholar]
  20. Price D. J., Sleigh J. D. Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics. Lancet. 1970 Dec 12;2(7685):1213–1215. doi: 10.1016/s0140-6736(70)92179-3. [DOI] [PubMed] [Google Scholar]
  21. Roholt K., Nielsen B., Kristensen Pharmacokinetic studies with mecillinam and pivmecillinam. Chemotherapy. 1975;21(3-4):146–166. doi: 10.1159/000221856. [DOI] [PubMed] [Google Scholar]
  22. Schmidt H., From E., Heydenreich G. Bacteriological examination of rectal specimen during long-term oxytetracycline treatment for acne vulgaris. Acta Derm Venereol. 1973;53(2):153–156. [PubMed] [Google Scholar]
  23. Shaw E. J., Datta N., Jones G., Marr F. M., Froud W. J. Effect of stay in hospital and oral chemotherapy on the antibiotic sensitivity of bowel coliforms. J Hyg (Lond) 1973 Sep;71(3):529–534. doi: 10.1017/s0022172400046519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sogaard H., Zimmermann-Nielsen C., Siboni K. Antibiotic-resistant gram-negative bacilli in a urological ward for male patients during a nine-year period: relationship to antibiotic consumption. J Infect Dis. 1974 Dec;130(6):646–650. doi: 10.1093/infdis/130.6.646. [DOI] [PubMed] [Google Scholar]
  25. Speller D. C., Bruten D. M. Faecal flora after prolonged co-trimoxazole treatment. Br Med J. 1972 Aug 12;3(5823):416–416. doi: 10.1136/bmj.3.5823.416-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tybring L. Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: in vitro evaluation. Antimicrob Agents Chemother. 1975 Sep;8(3):266–270. doi: 10.1128/aac.8.3.266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Verrier Jones E. R., Asscher A. W. Treatment of recurrent bacteriuria with pivmecillinam (FL 1039). J Antimicrob Chemother. 1975 Jun;1(2):193–196. doi: 10.1093/jac/1.2.193. [DOI] [PubMed] [Google Scholar]
  28. Wise R., Reeves D. S., Symonds J. M., Wilkinson P. J. A clinical investigation of pivmecillinam. A novel beta-lactam antibiotic in the treatment of urinary tract infections. Chemotherapy. 1976;22(5):335–339. doi: 10.1159/000221942. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES